Tumor necrosis factor (TNF)-a activates a diverse array of signaling pathways in vascular endothelial cells (ECs), leading to the inflammatory phenotype that contributes to the vascular dysfunction and neutrophil emigration in patients with sepsis. To date, it is not well understood what key regulator might coordinate signaling pathways to achieve inflammatory response in TNF-a-stimulated ECs. This study investigated the role of dual specificity phosphatase-6 (DUSP6) in the regulation of endothelial inflammation. Using knockout mice, we found that DUSP6 is important for TNF-a-induced endothelial intercellular adhesion molecule-1 (ICAM-1) expression in aorta and in vein. Moreover, genetic deletion of Dusp6 in pulmonary circulation significantly alleviated the susceptibility of mice to lung injury caused by neutrophil recruitment during experimental sepsis induced by TNF-a or lipopolysaccharide (LPS). The role of DUSP6 was further investigated in primary human umbilical vein endothelial cells (HUVECs). Employing RNAi approach in which endogenous DUSP6 was ablated, we showed a critical function of DUSP6 to facilitate TNF-a-induced ICAM-1 expression and endothelial leukocyte interaction. Interestingly, DUSP6-promoted endothelial inflammation is independent of extracellular signaling-regulated kinase (ERK) signaling. On the other hand, inducible DUSP6 leads to activation of canonical nuclear factor (NF)-jB-mediated transcription of ICAM-1 gene in TNFa-stimulated human ECs. These results are the first to demonstrate a positive role of DUSP6 in endothelial inflammation-mediated pathological process and the underlying mechanism through which DUSP6 promotes NF-jB signaling in the inflamed ECs. Our findings suggest that manipulation of DUSP6 holds great potential for the treatment of acute inflammatory diseases.
Tumor necrosis factor (TNF)-a activates a diverse array of signaling pathways in vascular endothelial cells (ECs), leading to the inflammatory phenotype that contributes to the vascular dysfunction and neutrophil emigration in patients with sepsis. To date, it is not well understood what key regulator might coordinate signaling pathways to achieve inflammatory response in TNF-a-stimulated ECs. This study investigated the role of dual specificity phosphatase-6 (DUSP6) in the regulation of endothelial inflammation. Using knockout mice, we found that DUSP6 is important for TNF-a-induced endothelial intercellular adhesion molecule-1 (ICAM-1) expression in aorta and in vein. Moreover, genetic deletion of Dusp6 in pulmonary circulation significantly alleviated the susceptibility of mice to lung injury caused by neutrophil recruitment during experimental sepsis induced by TNF-a or lipopolysaccharide (LPS). The role of DUSP6 was further investigated in primary human umbilical vein endothelial cells (HUVECs). Employing RNAi approach in which endogenous DUSP6 was ablated, we showed a critical function of DUSP6 to facilitate TNF-a-induced ICAM-1 expression and endothelial leukocyte interaction. Interestingly, DUSP6-promoted endothelial inflammation is independent of extracellular signaling-regulated kinase (ERK) signaling. On the other hand, inducible DUSP6 leads to activation of canonical nuclear factor (NF)-jB-mediated transcription of ICAM-1 gene in TNFa-stimulated human ECs. These results are the first to demonstrate a positive role of DUSP6 in endothelial inflammation-mediated pathological process and the underlying mechanism through which DUSP6 promotes NF-jB signaling in the inflamed ECs. Our findings suggest that manipulation of DUSP6 holds great potential for the treatment of acute inflammatory diseases.
Introduction
A semipermeable barrier lining along vessels, the endothelium regulates vascular tone as well as the exchange of fluids and solutes between the blood and interstitial space, thus maintaining physiological homeostasis. Because endothelial cells form the first tissue layer to have contact with blood, perturbations in blood composition may rapidly cause vascular dysfunction. One such perturbation present in blood is an increased level of tumor necrosis factor (TNF)-a, a cytokine that is predominantly produced by activated macrophages and T lymphocytes in response to allergen and pathogen invasion [1, 2] . Once this cytokine interacts with receptors on the endothelium, TNF-ainduced signal transduction initiates proinflammatory changes, including expression of adhesion molecules and increase in leukocyte adhesion for transendothelial migration [1, 2] . Recent studies have further demonstrated that TNF-a promotes endothelial inflammation and subsequent vascular dysfunction through recruitment of neutrophils [3] . One of the well-defined human diseases contributed by the action of TNF-a is sepsis. The initial release of cytokines including TNF-a stimulate inflammation in systemic or pulmonary circulation, leading to recruitment of neutrophils to the sites of infection such as lung and liver often seen in patients with sepsis [4, 5] . Detrimental accumulation of neutrophils may cause tissue damage and organ failure [6] , thus being correlated positively with sepsismediated morbidity and mortality [7, 8] .
Before transendothelial migration can occur at the site of inflammation, neutrophil must adhere firmly to endothelium on the surface of vascular bed. This key event is controlled by inducible expression of adhesion molecules on endothelial plasma membrane in response to TNF-a stimulation [9, 10] . It has been well-characterized that endothelial intercellular adhesion molecule-1 (ICAM-1), which functions as a ligand for b2 (CD11/ CD18)-integrin, plays an essential role in neutrophil recruitment at the site of acute inflammation [11] [12] [13] [14] . Through a strong bond between ICAM-1 and b2-integrin, neutrophil is arrested on the surface of endothelium [15] . Because of its critical function in inflammation, the level of endothelial ICAM-1 is robustly increased upon stimulation. It was demonstrated that TNF-a-induced signal transduction switches on the canonical nuclear factor (NF)-jB-dependent transcriptional pathway, thus driving the inducible expression of endothelial ICAM-1 [16] . This finding was further supported by the identification of consensus motifs on the promoter regions of ICAM-1 gene that is specifically targeted by the NF-jB dimers [17] .
Due to the important role of NF-jB-dependent induction of ICAM-1 during endothelial inflammation, this signaling pathway must be controlled precisely under TNF-a stimulation. In this context, dual specificity phosphatases (DUSPs;~60 genes in human genome [18] ) are potential players because many of them have been characterized as immediate early genes whose expression is highly susceptible to extracellular stimuli including TNF-a [19, 20] . However, available data so far are limited to define the function of DUSPs in the onset of endothelial inflammation. Using primary human umbilical vein endothelial cells (HUVECs) in the experiments, previous studies suggested that DUSP1 might inhibit TNF-a-promoted inflammatory responses [21, 22] potentially mediated by suppression of E-selectin expression [23] . It was subsequently demonstrated that DUSP16 alleviated the expression of vascular cell adhesion molecule-1 (VCAM-1), thus also acting as an anti-inflammatory regulator in HUVECs stimulated with TNF-a [20] . Interestingly, these studies did not show the direct involvement of endothelial DUSP1 or DUSP16 in the canonical signaling pathway of NF-jB-promoted ICAM-1 expression. Moreover, overexpression of DUSP4 in HUVECs did not change the level of TNF-a-stimulated ICAM-1 induction [24] , suggesting a negligible effect of this phosphatase on the activity of NF-jB-mediated transcription of ICAM-1 gene. Clearly, additional investigations are required to characterize the role of other DUSPs in the onset of endothelial inflammation.
In the present study, we examined whether and how DUSP6 (also named MKP-3, MAP kinase phosphatase 3) might participate in the proinflammatory response. Using knockout mice, we inspected the in vivo function of DUSP6 in vascular inflammation, and explored the regulatory role that endothelial DUSP6 plays in pulmonary neutrophil recruitment during experimental sepsis induced by lipopolysaccharide (LPS) or TNF-a, a pathological process depending on the interaction between ICAM-1 and b2 (CD11/CD18)-integrin [25, 26] . We further depicted the underlying mechanism through which DUSP6 promotes the inducible expression of ICAM-1 via activation of the NF-jB signaling pathway in primary human endothelial cells treated with TNF-a.
Results
TNF-a-induced ICAM-1 expression on the endothelial layer of aorta and vein is attenuated in Dusp6 À/À Mice We began our experiments by examining the in vivo role of DUSP6 in regulating endothelial inflammation using DUSP6 null mice (Dusp6 À/À strain B6;129-Dusp6 tm1Jmol /J [27] ). To measure the degree of inflammatory response in animal tissues, we performed the immunohistochemistry (IHC) staining on aorta and inferior vena cava (IVC) with a specific anti-ICAM-1 antibody. As shown in Fig. 1A , after tail vein injection with TNF-a (5 lgÁkg À1 ) for 16 h, there was a significant increase in levels of ICAM-1 on the endothelial layer of both aorta and IVC isolated from the wild-type (WT) control mice (B6129SF2/J). Pairs of WT and Dusp6 À/À mice were then examined under various conditions. Basal expression of endothelial ICAM-1 was low regardless of the presence or absence of Dusp6 gene (Fig. 1B) . Interestingly, although endothelial ICAM-1 expression on the surface of aorta and IVC was robustly enhanced in the WT mice exposed to TNF-a, its level in the Dusp6 À/À mice injected with TNF-a remained low (Fig. 1C,D) . Quantitative analyses of IHC images using tissues isolated from multiple animals revealed a significant difference in ICAM-1 levels on endothelial layer of aorta ( Fig. 1E ) and IVC ( Fig. 1F ) between the WT and Dusp6 À/À mice under TNF-a stimulation. These results suggest that DUSP6 may function as a positive regulator to promote inflammation through increased expression of endothelial ICAM-1.
Deficiency of DUSP6 protects mice from acute lung injuries during experimental sepsis
We next investigated whether DUSP6 regulates the pathological process of sepsis, which is a severe medical condition characterized by a systemic inflammatory response to infection [6] . We particularly focused on the potential role of DUSP6 involved in inflammatory consequence of sepsis within the pulmonary circulation. The lung is continuously exposed to circulating pathogen-associated molecular patterns such as endotoxin lipopolysaccharide (LPS) [6, 14] , which stimulates the expression of endothelial ICAM-1 and thus promoting neutrophil infiltration-dependent pulmonary injury through release of TNF-a [28] . In addition, pulmonary microvascular endothelial cells respond to TNF-a and LPS as evidenced by NF-jB activation and surface ICAM-1 expression [29] , suggesting that the sepsis in lung is an ideal model for examining the role of DUSP6 in endothelial inflammation. We tested our hypothesis by intraperitoneal injection of WT and Dusp6 À/À mice with TNF-a (0.1 mgÁkg À1 ) or LPS (10 mgÁkg
À1
). After 24 h of treatment, lung sections taken from the mice were subjected to staining with hematoxylin and eosin (H&E) or anti-ICAM-1 antibody. As shown in Fig. 2A , a significant degree of histologic lung injury indicated by interalveolar septal thickening and notable infiltration of inflammatory cells, such as macrophages and monocytes, were observed in the WT mice exposed to TNF-a or LPS. Interestingly, these tissue damages were attenuated in TNF-a or LPS-treated Dusp6 À/À mice ( Fig. 2A) .
Moreover, although ICAM-1 staining on the surface of alveolar walls was increased in the WT mice exposed to TNF-a or LPS, this stimulation-induced ICAM-1 expression was alleviated in the Dusp6 À/À mice (Fig. 2B) . Due to the specific function of ICAM-1 in recruiting neutrophil [11] [12] [13] [14] , we further assessed pulmonary neutrophil infiltration by measuring myeloperoxidase (MPO) activity in the lung tissues. MPO is an important enzyme in defense of the organism through production of hypochlorous acid and abundantly present in azurophilic granules of polymorphonuclear neutrophils. The quantitative determination of MPO activity indicates the degree of neutrophil infiltration. As expected, the basal levels of lung MPO activity were low and comparable between the WT and Dusp6 À/À mice (Fig. 2C) . Importantly, although the MPO activity was increased threefold or fivefold in the WT mice receiving TNF-a or LPS treatment, respectively, such change was significantly lower in the Dusp6 À/À mice (Fig. 2C) . These results suggest that Dusp6 À/À mice were protected from pulmonary neutrophil infiltration and subsequent lung injury in the mouse model of experimental sepsis.
Pulmonary endothelial DUSP6 positively regulates LPS-induced neutrophil recruitment in mice
To confirm that the decreased susceptibility to lung injury in the knockout mice ( Fig. 2) is caused by the deficiency of endothelial DUSP6, we adoptively transferred neutrophils from the WT mice into the irradiated WT or Dusp6 À/À -recipient mice and subsequently induced experimental sepsis in the recipient mice. We noticed that, after 24 h of irradiation, the number of total leukocytes in peripheral blood of mice with either genotype was diminished significantly (Fig. 3A) , indicating an effective removal of intrinsic neutrophils in recipient mice by this treatment. In addition, the irradiated WT recipient mice that were transferred with purified polymorphonuclear leukocytes (PMNs, Fig. 3B ) developed more severe lung injury than the mice without transfer of PMNs after LPS injection for 4 h (Fig. 3C ). Based on these pilot studies, we designed the experimental workflow illustrated in Fig. 3D for examining the potential role of pulmonary endothelial DUSP6 in the neutrophil recruitment under the LPS stimulation. Following this protocol, we measured the MPO activity in lung tissues harvested from the WT or Dusp6 À/À -recipient mice upon the completion of LPS exposure. As shown in Fig. 3E , the increased level of neutrophil infiltration into the lung tissues by the adoptive transfer of PMNs was observed only in the WT, but not in the Dusp6 À/À -recipient mice. Data collectively suggested that endothelial DUSP6 plays a key role in neutrophil recruitment during acute pulmonary inflammation.
Inducible DUSP6 regulates TNF-a-directed inflammatory responses in HUVECs
The experiments using genetically deficient mice have clearly demonstrated that DUSP6 acts to promote inflammatory response in vivo (Figs 1-3 ). To further elucidate the underlying mechanism of this signaling pathway, we examined the role of DUSP6 in primary endothelial cells exposed to TNF-a. For this, we worked on commonly used HUVECs, which show LPS-and TNF-a-induced NF-jB activation or surface ICAM-1 expression in a level similar to the response of human pulmonary microvascular endothelial cells [29] . In HUVECs treated with TNF-a, we observed that DUSP6 was rapidly induced in a transient manner and peaked at 1-2 h, followed by a gradual increase in ICAM-1 expression (data not shown). Interestingly, ablation of DUSP6 via specific siRNA led to significant suppression of ICAM-1, which was otherwise robustly expressed between 4 and 6 h of TNF-a treatment (Fig. 4A ). To validate the specific function of DUSP6 in TNF-a signaling, we performed a rescue experiment by ectopically expressing a phosphataseactive, WT form of DUSP6 in HUVECs, in which endogenous DUSP6 had been knocked down. As depicted in Fig. 4B , when the WT form of DUSP6 was re-expressed in RNAi-ablated HUVECs, there was a significant increase in the level of ICAM-1 in response to TNF-a stimulation. To further examine the involvement of enzymatic activity in this context, we expressed the phosphatase-dead C293S mutant form of DUSP6 in the siRNA-transfected cells. Clearly, the mutant DUSP6 was capable of promoting although the degree of rescue effect mediated by the mutant DUSP6 was less than the WT DUSP6 (Fig. 4C ). We further investigated whether the endothelial leukocyte interaction, which is primarily governed by the accumulation of adhesion molecules on the surface of endothelium [30] , is regulated by DUSP6. As expected, the binding of U937 monocytes to TNF-a-exposed HUVECs was inhibited when DUSP6 in HUVECs was knocked down (Fig. 5) . A loss of endothelial leukocyte interaction in response to DUSP6 ablation was restored by re-expression of the WT form or the C293S mutant form of DUSP6 (Fig. 5) . Collectively, these results suggest a critical role that DUSP6 plays in TNF-a-promoted endothelial inflammation.
DUSP6-promoted ICAM-1 expression in TNF-astimulated HUVECs is independent of ERK
Having demonstrated the involvement of DUSP6 in TNF-a-stimulated ICAM-1 expression, we next investigated whether down-regulation of ERK by DUSP6, the primary function of DUSP6 thus far identified [31] , is essential for this process. We first showed the detailed time-dependent regulation of MAPKs by DUSP6 in HUVECs exposed to TNF-a. The immediate activation of ERK was terminated at 1 h poststimulation in control cells; however, ERK activation was sustained over the duration of 1-6 h after TNF-a treatment in RNAi-ablated cells (Fig. 6 ). This observation led us to examine the effect of ERK knockdown in DUSP6 RNAi-ablated HUVECs. To our surprise, DUSP6 deficiency-caused low levels of ICAM-1 remained unchanged when ERK expression was suppressed by the specific siRNA (Fig. 7A ). Such a finding provided an alternative view that DUSP6's role involved in inflammatory response of endothelium is likely independent of ERK. If so, the role of ERK in TNF-a-induced expression of ICAM-1 might be negligible. To further examine the role of ERK, we treated HUVECs with the specific inhibitor U0126. Our data showed that suppression of ERK activity did not alter the level of ICAM-1 in HUVECs exposed to TNF-a (Fig. 7B) . Moreover, knockdown of ERK by siRNA did not change the level of TNFa-promoted ICAM-1 in HUVECs (Fig. 7C ). Additional tests further demonstrated that forced expression of the dominant-negative mutant form of ERK (K52R mutation) [32, 33] did not affect the expression of ICAM-1 in HUVECs stimulated with TNF-a (Fig. 7D ). These findings support the notion that DUSP6-promoted inducible ICAM-1 expression is an ERK-independent event (Fig. 7A) . Additional observation showed that the peaked JNK activation was slightly enhanced by DUSP6 knockdown in TNF-atreated HUVECs (Fig. 6) . Nonetheless, DUSP6 ablation-caused low level of ICAM-1 could not be restored when JNK expression was further suppressed by the specific siRNA (Fig. 8) . A negative role of ERK and JNK in DUSP6-promoted endothelial signaling suggested by our results is consistent with the previous report that MAP kinases do not participate in TNF-ainduced ICAM-1 expression [16] . It would be important to unravel whether other TNF-a signaling modules might be regulated by DUSP6 in the context of endothelial inflammation. mice were subjected to total body irradiation (9 Gy) or remained untreated. After 24 h, blood samples were taken by submandibular bleeding and total leukocytes were analyzed by flow cytometer. There is no obvious difference in total leukocytes between WT and Dusp6 À/À control mice. However, 24 h after irradiation, endogenous leukocytes were significantly ablated in both genotypes of mice. For flow cytometry analysis, 1% of the counting cells were taken for the image display. The quantitation of the cell number is shown in each panel. Data shown in A are representatives from three independent experiments (n = 2 mice per group). (B) Purified polymorphonuclear leukocytes (PMNs) isolated from the WT mice were subjected to flow cytometry analysis and the enriched fraction of neutrophils (circle R1 in the upper panels) was confirmed by double staining with specific markers Ly-6G and CD11b (shown in the lower panels). The upper images indicate 1% of control cells or 10% of purified PMNs being counted, respectively. The quantitation of circle R1 over total cell number was shown in each panel. (C) Purified PMNs from the WT donor mice were adoptively transferred to the irradiated recipient WT mice, followed by intraperitoneal injection with LPS (10 mgÁkg
À1
) into the recipient mice for 4 h. The neutrophil infiltration into lung was monitored by the myeloperoxidase (MPO) activity. Data shown in C are presented from three mice in each group (bar, the mean of each group; *P < 0.05). (D) Schematic illustration of the workflow to assess the potential function of pulmonary endothelial DUSP6 in LPSstimulated neutrophil infiltration in the lung tissue. The WT and Dusp6 À/À mice were subjected to irradiation. After recovery for 24 h, the irradiated recipients were adoptively transferred with purified PMNs from the WT donor mice via tail vein injection, followed by intraperitoneally (IP) treatment with LPS (10 mgÁkg
) for 4 h. (E) Lung homogenates were subjected to the activity measurement of neutrophil-specific myeloperoxidase (MPO). Data shown in E are presented from five, six, or seven mice in each group (N, the number of mice; bar, the mean of each group; *P < 0.05, **P < 0.01, ***P < 0.001, # no significant difference). Statistical significance was determined by Student's t-test.
DUSP6 promotes NF-jB transcriptional activity in HUVECs exposed to TNF-a It was suggested previously that activation of NF-jB is essential for expression of adhesion molecules in endothelium under inflammatory response [16] . Among six NF-jB binding elements found in the promoter region of ICAM-1 gene [17] , one particular site specifically recognized by p65 homodimer [34] was selected for characterization. The pilot test in COS-7 cells demonstrated the motif -187~-178 nucleotide to be the minimal ICAM-1 promoter that is activated in response to TNFa stimulation (Fig. 9) . We next examined whether inducible DUSP6 would promote the expression of ICAM-1 in HUVECs through activation of NF-jB. Using a specific inhibitor BAY-117082, we showed a critical role of NF-jB in TNF-a-mediated induction of ICAM-1 protein in HUVECs (Fig. 10A) . The role of DUSP6 in NF-jB-directed transcription of ICAM-1 gene was subsequently studied using the luciferase report assay as an indicator in TNF-a-treated HUVECs. Employing a reporter construct containing this specific p65/p65-binding element, we showed that transcriptional activity was gradually increased after TNF-a treatment in HUVECs and that the robust enhancement of luciferase activity occurred at 4 h poststimulation (Fig. 10B) . This led us to examine the role that DUSP6 plays in regulating NF-jB at this time. HUVECs were treated with specific siRNA which targets endogenous DUSP6 and subsequently transfected with the reporter vectors for measuring NF-jB transcriptional activity. Our results showed clearly that, upon the ablation of DUSP6, NF-jB-mediated transcription of ICAM-1 promoter was significantly suppressed (Fig. 10C) . Additional experiments further supported the positive role of DUSP6 in TNF-a-directed endothelial inflammation. Interestingly, either the WT or the C293S mutant form of DUSP6, when ectopically expressed in HUVECs, could activate the transcription of ICAM-1 promoter (Fig. 10D) . Together, these results suggest a phosphatase activity-independent role that DUSP6 plays in the canonical NF-jB signaling.
Discussion
DUSP6 has been identified as a phosphatase important for correct cell specification and differentiation during ligand-guided embryonic development [35, 36] . However, it remained unclear whether DUSP6 participates in the progression of disease conditions until a recent report to demonstrate a positive function that DUSP6 executes to activate gluconeogenesis in the liver of diet-induced obese mice [37] . The present work further highlights a role of DUSP6 in cytokine-stimulated endothelial inflammation and delineates the molecular mechanism through which this occurs. Collectively, these evidences suggest that DUSP6 is not only critical for correct signaling coordination during embryonic development as proposed previously [35, 36] but also involved in obesity-induced insulin resistance [37] or cytokine-promoted endothelial inflammation in adult animals. Using the mouse model of experimental sepsis in conjunction with adoptive transfer of neutrophils, we have defined a novel role of DUSP6 in pulmonary circulation response to inflammatory stimulation (Fig. 3) .
It has been known clearly that pulmonary infection results in robust emigration of neutrophils from the capillary bed into the alveolar space, leading to acute lung injuries often seen in patients with sepsis [14] . Moreover, previous studies showed that intratracheal exposure of LPS in mice induced a significant increase in ICAM-1 expression on capillary endothelial cells [13] and that TNF-a-stimulated neutrophil adhesion on human pulmonary capillary endothelial cells was an ICAM-1-dependent process [38, 39] . These previous data together with our current findings suggest a critical function of DUSP6 that drives inducible ICAM-1 expression within pulmonary capillary endothelial cells during acute inflammatory process. We propose that capillary endothelial DUSP6 is particularly important in the development of acute lung injury caused by infection of Escherichia coli or Pseudomonas aeruginosa, as the endotoxin produced by these bacteria elicits neutrophil emigration via a b2-integrin pathway [40] [41] [42] , which acts through ICAM-1 on the endothelial surface for strong binding [30] .
Although DUSP6 has been characterized as an ERK phosphatase [31] , it appears to function independently of ERK signaling under endothelial inflammation (Fig. 7) . Clearly, additional signaling pathway other than ERK might be regulated by DUSP6, leading to transcription of ICAM-1 gene in endothelium exposed to TNF-a (Fig. 10) . Our finding of phosphatase activity-independent activation of NF-jB by DUSP6 (Fig. 10D ) was in line with the observation that both WT and C293S mutant DUSP6 could promote inducible expression of ICAM-1 (Fig. 4C ) and endothelial leukocyte interaction (Fig. 5) . Collectively, these results suggest a previously uncharacterized function that DUSP6 plays to activate NF-jB during endothelial inflammation. It has been shown that DUSP6 is capable of shuttling between the cytoplasm and nucleus [43] . Thus, we proposed that a signaling network coordinated by DUSP6 in the nucleus 2-4 h after TNF-a stimulation, while ICAM-1 expression is increased in endothelial cells (Fig. 4A) , may promote transcription activity of NF-jB subsequently targeting the ICAM-1 promoter (Fig. 10B) . A recent study by proteomic and networking approaches has shown that VHR (Vaccinia H1-related protein/DUSP3), which was originally characterized as a JNK phosphatase [44] , may interact with nucleophosmin, HnRNP C1/ C2 (heterogenous nuclear ribonucleoprotein C1/C2), and nucleolin inside nucleus to regulate DNA repair and senescence in cancer cells exposed to irradiation [45] . These findings provide an alternative view to expand our understanding of DUSPs-mediated cellular function through a noncanonical process independent of MAP kinases. Currently, it is not known what signaling networks DUSP6 may regulate. More studies focusing on interactomics are required to clarify the function of DUSP6 that coordinates with yet-to-be-identified factors to promote NF-jBmediated ICAM-1 expression during inflammatory response in endothelium.
The mice with DUSP6 deficiency still showed response to TNF-a or LPS treatment, although the degree of neutrophil recruitment by lung in Dusp6 À/À mice was much lower than the WT counterparts (Figs 2 and 3) . Similarly, we observed a residual level of ICAM-1 in DUSP6-ablated HUVECs when exposed to TNF-a (Fig. 4) . These results suggest that, in addition to DUSP6, other phosphatases might be involved in the promotion of endothelial inflammation. Focusing on members of the DUSP family, we analyzed microarray data obtained from HUVECs exposed to TNF-a. Interestingly, among eight well-characterized DUSPs (DUSP1, 3, 4, 6, 9, 10, 11, and 12), DUSP6 and DUSP10 were the only two phosphatases that showed a significant increase in TNF-a-dependent mRNA expression (Data not shown). A recent study showed that DUSP10 deficiency exacerbates lung injury in a mouse sepsis model [46] . Although the specific function of endothelial DUSP10 was not clearly defined in this report, the available data suggested an inhibitory function of this phosphatase in inflammatory responses [46] . Therefore, we propose an indispensable role of DUSP6 in promoting endothelial inflammation under TNF-a or LPS stimulation. Further studies are required to examine whether and how other types of phosphatases, including atypical DUSPs, classical Tyr-specific and Ser/Thr-specific phosphatases, might coordinate with DUSP6 to activate NF-jB signaling for a robust response in endothelial cells.
In addition to ICAM-1, the expression of vascular cell adhesion molecule-1 (VCAM-1) on endothelial surface is also under the control of NF-jB in response to TNF-a stimulation [16] . Interestingly, DUSP6 appeared to be critical for the inducible VCAM-1 expression through NF-jB-dependent signaling in HUVECs exposed to TNF-a (data not shown). Collectively, our results illustrated an important role that DUSP6 plays in NF-jB-mediated transcription of ICAM-1 and VCAM-1 genes. Nonetheless, we propose that inducible expression of ICAM-1 is the primary downstream effector of endothelial DUSP6 during the pulmonary neutrophil infiltration (Figs 2 and 3) , as the b2-integrin expressed on the surface of neutrophil interacts specifically with ICAM-1 but not VCAM-1 [30] . The inducible expression of VCAM-1, on the other hand, manifests a specific ligand for the integrin a4b1 (VLA-4), which appears on the surface of monocyte, B and T lymphocytes but not neutrophil [30] . Further investigations may reveal a new function of DUSP6 in regulating VCAM-1-dependent recruitment of leukocytes during vascular inflammation.
Our data provided an opportunity to explore the possibility of subduing inflammatory disorders. From the perspective of drug development for suppression of inflammatory responses, interference of DUSP6 level may be a feasible strategy for manipulating NF-jB pathway. Due to the ubiquitous expression profiles of NF-jB as well as its involvement in normal cellular physiology, it is expected that the application of inhibitors against NF-jB may lead to profound side effects in humans [47, 48] . Still, the inducible expression of DUSPs follows a cell type-specific and disease context-dependent manner [49] , rendering these phosphatases promising drug targets. Our present study suggests that the development of new compounds, which disrupt signaling networks coordinated by DUSP6, may be used in novel therapeutic strategies for the treatment of patients with sepsis through the reduction in pulmonary endothelial inflammation.
Materials and methods
Mice DUSP6-null mice (B6;129X1-Dusp6 tm1Jmol /J [27] , stock number 009069, backcrosses number = 1) and their appropriate control mice (B6129SF2/J, stock number 101045, recommended by the manufacture http://jaxmice.jax.org/stra in/009069.html) were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). Mice were bred and maintained in a specific pathogen-free (SPF) animal facility in a room subjected to a 12-h light/dark cycle and maintained at constant temperature (22°C) and humidity (55% 
Immunohistochemistry staining and image quantification
Organs from TNF-a-, LPS-(Sigma-Aldrich/Merck, Darmstadt, Germany), or PBS-treated mice were harvested, rinsed in ice-cold PBS, fixed in 4% paraformaldehyde and then embedded in paraffin. TNF-a and LPS-induced experimental sepsis, MPO assay and neutrophil adoptive transfer were adoptively transferred to recipient mice by intravenous injection, followed by intraperitoneal injection with 10 mgÁkg À1 of LPS in a total volume of 200 lL. After 4 h, mice were sacrificed. Lung was isolated and processed for H&E staining, immunohistochemistry staining with anti-ICAM-1 antibody and MPO assay.
Neutrophil isolation from mouse blood
The procedure of neutrophil isolation was performed according to the protocol described previously [50] . In brief, whole blood from adult donor mouse was collected in tubes containing EDTA and then mixed with an equal volume of PBS. The cells were separated onto a three-layer Percoll gradient of 78, 69, and 52% Percoll diluted in PBS by centrifugation at 1500 g for 35 min at room temperature. The fraction of neutrophils at the 69-78% interface was harvested and washed with PBS containing 1% BSA once. The residual red blood cells were then eliminated by RBC Lysis Buffer (BD Biosciences, San Jose, CA, USA) at 37°C for 3 min. After two times of wash with PBS containing 1% BSA, the purified neutrophils were suspended in PBS and used immediately. The purity and viability of purified neutrophils were confirmed by Ly6G/CD11b double staining and trypan blue exclusion, respectively.
Flow cytometry analysis
Cells were incubated with Ly6G-FITC (11-5931-82), CD11b-PerCP-Cyanine5. (from the National RNAi Core Facility, Academia Sinica) were tested initially by lentivirus-mediated infection. According to the knockdown efficiency of DUSP6 by shRNA constructs, a specific clone (TRCN0000355536) was chosen. Due to the poor viability of virus-infected HUVECs, an alternative approach of transfection was established. The sequence of selected shRNA clone targeting the DUSP6 3 0 -UTR was used as a template for synthesis of siRNA duplexes (sequence shown in Table 1 ), which were ultimately applied to knockdown of the endogenous DUSP6 but not the ectopically expressed DUSP6.
Immunoblotting and antibodies
Aliquots of total lysates (15-20 lg) were subjected to SDS-PAGE and transferred to nitrocellulose membranes, and then incubated with antibodies recognizing human ICAM-1 (4915), pERK (9101), ERK (9102), pp38 MAPK (9211), p38 MAPK (9212), pJNK (9251), JNK (9525), IjB-a (9242, all from Cell Signaling); Tubulin (T5168), Flag (F3165, both from Sigma-Aldrich/Merck), and DUSP6 (a gift from Dr. Stephen Keyse (University of Dundee, Dundee, UK) and described previously [52] ). The specific signals were visualized by ECL Reagents (GE Healthcare).
Monocyte adhesion assay
Endothelial-monocyte adhesion assay was performed following the protocol described previously [53] . HUVECs (2 9 10 5 cells per reaction for siRNA transfection or 3.5 9 10 5 cells per reaction for expression vector transfection) were transiently transfected with siRNA or expression vectors by electroporation, and then subsequently seeded on a 24-well plate for overnight. Once reaching to confluence, cells were treated with TNF-a (10 ngÁmL À1 ) for 4 h. At the meantime, monocytic U937 (4.5 9 10 5 ) were labeled with 10 lgÁmL À1 of BCECF-AM (Invitrogen/Thermo Fisher Scientific) at 37°C for 30 min in dark, subsequently washed twice with PBS to remove free dye, and then suspended in HUVEC culture medium ready for use. Labeled U937 cells were added onto a monolayer of TNF-a-treated HUVECs and then incubated for 1 h. Nonadherent U937 cells were removed by two gentle washes with phenol-red free M199 medium. The fraction of HUVEC-associated U937 cells was quantified by a fluorescence analyzer (Infinite F200, Tecan/ Thermo Fisher Scientific) using excitation and emission wavelength at 485 and 535 nm respectively. The images of adherent U937 cells on HUVEC monolayer were captured using a fluorescence microscope (BX50, Olympus).
Construction of expression vectors and luciferase reporter plasmids
The full-length DUSP6 cDNA was obtained by reverse transcription of total mRNA isolated from HUVECs and subcloned into an N-terminal pFlag-CMV2 vector (SigmaAldrich/Merck). The phosphatase-dead C293S mutant of DUSP6 was generated by site-directed mutagenesis according to the standard procedure. The expression vector of full-length mouse ERK2 (in pcDNA3.1, Thermo Fisher Scientific) was a gift from Dr. Nicholas K. Tonks (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA). The dominant-negative K52R mutant of ERK2 was generated by site-directed mutagenesis according to the standard procedure. The ICAM-1 luciferase reporter construct was generated by insertion of NF-jB-binding element to a pGL4.27 [luc2P/minP/Hygro] firefly luciferase vector (Promega, Madison, WI, USA), which contains a multiple cloning region for insertion of a response element of interest upstream of a minimal promoter and the luciferase reporter gene luc2P. The DNA duplex sequence 5 0 -TGGAAATTCC-3 0 located at -187 nucleotides of the ICAM-1 promoter was synthesized with a flanking restriction enzyme site KpnI/BglII. The KpnI/BglII digested-DNA duplex was then inserted into KpnI/BglII digested-pGL4.27 vector. All clones were verified by sequencing.
NF-jB reporter assay
Human umbilical vein endothelial cells (3.5 9 10 5 cells per reaction in a single well of a 12-well culture plate) were transiently transfected with 0.5 lg of the reporter plasmid and 0.025 lg of the pRL-null vector (Renilla internal control reporter vector, Promega) by electroporation using the Neon Transfection System (Invitrogen/Thermo Fisher Scientific) according to manufacturer's instructions. Cells were seeded on a 12-well plate for overnight and then treated with TNF-a (10 ngÁmL
À1
) for 4 h. An aliquot of total lysates was subjected to specific luciferase activity was analyzed using the Dual-Luciferase Reporter Assay System (Promega) with a luminometer (Luminoskan Ascent, Thermo Fisher Scientific).
Statistical analysis
Values were expressed as means AE SD. Statistical significance was determined using a Student's t-test. A P-value <0.05 was considered significant.
